Publications by authors named "Fred D Lublin"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

82,050

Total Likes

8,021

Extended Reach

82,050

Social Features

3
D
Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria".
Chris H Polman, Stephen C Reingold, Gilles Edan, Massimo Filippi, Hans-Peter Hartung, Ludwig Kappos, Fred D Lublin, Luanne M Metz, Henry F McFarland, Paul W O'Connor

Ann Neurol· December 2005

Videos about Article: user user

2 1 3 2 3

View All Article and Social Media Activity
D
Depression Polygenicity and Disease Activity and Disability Worsening in Multiple Sclerosis.
Ali Manouchehrinia, Kathryn C Fitzgerald, Amber Salter, Ruth Ann Marrie, Lars Alfredsson, Fred D Lublin

Ann Neurol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cognition in multiple sclerosis within the modern diagnostic and treatment era.
James F Sumowski, Sarah Levy, Ilana Katz Sand, Rachel Brandstadter, Emily Dvorak, Fred D Lublin

Brain· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AI-driven reclassification of multiple sclerosis progression.
Habib Ganjgahi, Dieter A Häring, Piet Aarden, Gordon Graham, Yang Sun, Fred D Lublin

Nat Med· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Composite Confirmed Disability Worsening/Progression Is a Useful Clinical Endpoint for Multiple Sclerosis Clinical Trials.
Ludwig Kappos, Sean Yiu, Frank Dahlke, Timothy Coetzee, Gary R Cutter, Fred D Lublin

Neurology· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polygenic liability for anxiety in association with comorbid anxiety in multiple sclerosis.
Kaarina Kowalec, Arvid Harder, Casandra Dolovich, Kathryn C Fitzgerald, Amber Salter, Fred D Lublin

Ann Clin Transl Neurol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relapse recovery in relapsing-remitting multiple sclerosis: An analysis of the CombiRx dataset.
Marcus W Koch, Ester Moral, Luis Brieva, Jop Mostert, Eva Mm Strijbis, Fred D Lublin

Mult Scler· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Worsening MS-A reappraisal of how we characterize the MS disease course.
Fred D Lublin

Mult Scler· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Do the current MS clinical course descriptors need to change and if so how? A survey of the MS community.
Alan J Thompson, Marcello Moccia, Maria Pia Amato, Peter A Calabresi, Marcia Finlayson, Fred D Lublin

Mult Scler· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of baseline age and disease duration on the efficacy and safety of siponimod in patients with active SPMS: Post hoc analyses from the EXPAND study.
Le H Hua, Amit Bar-Or, Stanley L Cohan, Fred D Lublin, Patricia K Coyle

Mult Scler Relat Disord· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MS becomes a treatable disease: 30 years later.
Fred D Lublin, Stephen C Krieger

Mult Scler· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum neurofilament light-chain levels and long-term treatment outcomes in relapsing-remitting multiple sclerosis patients: A post hoc analysis of the randomized CombiRx trial.
Gary Cutter, Richard A Rudick, Carl de Moor, Carol M Singh, Elizabeth Fisher, Fred D Lublin

Mult Scler J Exp Transl Clin· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of neurotrophic factor secreting mesenchymal stem cells in progressive multiple sclerosis.
Jeffrey A Cohen, Fred D Lublin, Christoper Lock, Daniel Pelletier, Tanuja Chitnis

Mult Scler· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How patients with multiple sclerosis acquire disability.
Fred D Lublin, Dieter A Häring, Habib Ganjgahi, Alex Ocampo, Farhad Hatami

Brain· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Confirming a Historical Diagnosis of Multiple Sclerosis: Challenges and Recommendations.
Andrew J Solomon, Georgina Arrambide, Wallace Brownlee, Anne H Cross, María I Gaitan, Fred D Lublin

Neurol Clin Pract· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CONCERTO: A randomized, placebo-controlled trial of oral laquinimod in relapsing-remitting multiple sclerosis.
Giancarlo Comi, Yuval Dadon, Nissim Sasson, Joshua R Steinerman, Volker Knappertz, Fred D Lublin

Mult Scler· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early first-line treatment response and subsequent disability worsening in relapsing-remitting multiple sclerosis.
Marcus W Koch, Jop Mostert, Pavle Repovic, James D Bowen, Jerry S Wolinsky, Fred D Lublin

Eur J Neurol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of the EDSS, Timed 25-Foot Walk, and the 9-Hole Peg Test as Clinical Trial Outcomes in Relapsing-Remitting Multiple Sclerosis.
Marcus W Koch, Jop P Mostert, Jerry S Wolinsky, Fred D Lublin, Bernard Uitdehaag

Neurology· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of Age With Contrast-Enhancing Lesions Across the Multiple Sclerosis Disease Spectrum.
Marcus W Koch, Jop Mostert, Yinan Zhang, Jerry S Wolinsky, Fred D Lublin

Neurology· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Depression and cognitive function in early multiple sclerosis: Multitasking is more sensitive than traditional assessments.
Lisa Glukhovsky, Daniel Kurz, Rachel Brandstadter, Victoria M Leavitt, Stephen Krieger, Fred D Lublin

Mult Scler· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sleep disturbance and memory dysfunction in early multiple sclerosis.
James F Sumowski, Sam Horng, Rachel Brandstadter, Stephen Krieger, Victoria M Leavitt, Fred D Lublin

Ann Clin Transl Neurol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disability Outcomes in the N-MOmentum Trial of Inebilizumab in Neuromyelitis Optica Spectrum Disorder.
Romain Marignier, Jeffrey L Bennett, Ho Jin Kim, Brian G Weinshenker, Sean J Pittock, Fred D Lublin

Neurol Neuroimmunol Neuroinflamm· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hippocampal volume is more related to patient-reported memory than objective memory performance in early multiple sclerosis.
Lisa Glukhovsky, Rachel Brandstadter, Victoria M Leavitt, Stephen Krieger, Korhan Buyukturkoglu, Fred D Lublin

Mult Scler· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pandemic forward: Lessons learned and expert perspectives on multiple sclerosis care in the COVID-19 era.
Jacqueline A Nicholas, Robert K Shin, Enrique Alvarez, Barry Hendin, Kavita V Nair, Fred D Lublin

Mult Scler Relat Disord· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of MD1003 (high-dose biotin) in patients with progressive multiple sclerosis (SPI2): a randomised, double-blind, placebo-controlled, phase 3 trial.
Bruce A C Cree, Gary Cutter, Jerry S Wolinsky, Mark S Freedman, Giancarlo Comi, Fred D Lublin

Lancet Neurol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The 2013 clinical course descriptors for multiple sclerosis: A clarification.
Fred D Lublin, Timothy Coetzee, Jeffrey A Cohen, Ruth A Marrie, Alan J Thompson

Neurology· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis